Person avatar: Niklas Kouparanis

Niklas Kouparanis

General Management / Strategy

Company logo: farmako


Founder & CEO


Niklas Kouparanis was the second employee and authorized officer of one of the currently leading German companies for medical cannabis. He shaped the industry as an established expert in the field, consultant to European governments, and supervisor to one of the first German-Canadian market entrances. 18 days after market entry in March 2019 Farmako has been the leading European independent distributor for pharmaceutical cannabis. Farmako has signed the world's largest import agreement, securing 50 tonnes of pharmcaceutical flowers and oil from Pharmacann Polska. In February 2019 Farmako has registered a patent for the biosynthetical production of cannabinoids. In April 2019 the company has signed the first agreement for the mass production of CBD.

Conference attendance

NOAH19 Berlin

Related Companies

Primary Company Info

Frankfurt am Main
Year Founded:
Active Markets:
Western Europe All, Northern Europe All,

Edition June 2019

The latest NOAH Bible is out! Featuring an update on our conferences and a valuation / industry KPI snapshot for:

  • Company valuation work
  • Peer group analysis
  • Industry KPI benchmarking
  • Financial analysis